Abdominal wall hematoma and hemoperitoneum in an individual with concomitant use of warfarin and moxifloxacin.
Chien-Ming
CM
Chao
Sheng-Hsiang
SH
Lin
Chih-Cheng
CC
Lai
D034861:Abdominal Wall; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D001372:Aza Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D024841:Fluoroquinolones; D006350:Heart Valve Prosthesis; D006406:Hematoma / Q000139:chemically induced*; D006465:Hemoperitoneum / Q000139:chemically induced*; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000601:surgery*; D000077266:Moxifloxacin; D018410:Pneumonia, Bacterial / Q000188:drug therapy*; D011804:Quinolines / Q000009:adverse effects* / Q000627:therapeutic use; D013923:Thromboembolism / Q000517:prevention & control*; D014057:Tomography, X-Ray Computed; D014859:Warfarin / Q000009:adverse effects* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D014859:Warfarin; D000077266:Moxifloxacin